HemaCore Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
HemaCore General Information
Description
Developer of advanced medical technologies and medical devices designed to be used for diagnosing blood-clotting disorders. The company's technologies focus on the creation of instant-diagnostic devices for determining, monitoring, and prognosis of blood coagulation disorders like bleeding and thrombosis and various clotting disorders that can lead to heart attack and stroke, enabling healthcare practitioners to avail efficient tools and devices for offering healthcare services.
Contact Information
Website
hemacore.com/enCorporate Office
- Nauchniy proezd
- 20 building 2
- Moscow, 117246
- Russia
Corporate Office
- Nauchniy proezd
- 20 building 2
- Moscow, 117246
- Russia
HemaCore Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Oct-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 25-Nov-2014 | Completed | Generating Revenue | |||
| 3. Grant | 19-Aug-2014 | Completed | Startup | |||
| 2. Debt - General | 01-Dec-2010 | $3M | $39.8M | Completed | Startup | |
| 1. Early Stage VC | 28-Apr-2010 | $36.8M | $36.8M | Completed | Startup |
HemaCore Comparisons
Industry
Financing
Details
HemaCore Competitors (36)
One of HemaCore’s 36 competitors is Oscor, a Corporate Backed or Acquired company based in Palm Harbor, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oscor | Corporate Backed or Acquired | Palm Harbor, FL | ||||
| Kardium | Private Equity-Backed | Burnaby, Canada | ||||
| Q-linea | Formerly VC-backed | Uppsala, Sweden | ||||
| Modality Dx | Venture Capital-Backed | Hillsboro, OR | ||||
| Grifols Diagnostic Solutions | Corporate Backed or Acquired | Emeryville, CA |
HemaCore Patents
HemaCore Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2704287-A1 | Method and apparatus for monitoring spatial fibrin clot formation | Active | 02-Nov-2007 | ||
| CA-2704287-C | Method and apparatus for monitoring spatial fibrin clot formation | Active | 02-Nov-2007 | ||
| EP-2215470-A1 | Method and apparatus for monitoring spatial fibrin clot formation | Active | 02-Nov-2007 | ||
| EP-2215470-B1 | Method and apparatus for monitoring spatial fibrin clot formation | Active | 02-Nov-2007 | ||
| US-20100261211-A1 | Method and apparatus for monitoring spatial fibrin clot formation | Inactive | 02-Nov-2007 | G01N33/4905 |
HemaCore Signals
HemaCore Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Skolkovo Foundation | Limited Partner | Minority |
HemaCore FAQs
-
When was HemaCore founded?
HemaCore was founded in 2010.
-
Where is HemaCore headquartered?
HemaCore is headquartered in Moscow, Russia.
-
What is the size of HemaCore?
HemaCore has 10 total employees.
-
What industry is HemaCore in?
HemaCore’s primary industry is Diagnostic Equipment.
-
Is HemaCore a private or public company?
HemaCore is a Private company.
-
What is HemaCore’s current revenue?
The current revenue for HemaCore is .
-
How much funding has HemaCore raised over time?
HemaCore has raised $41.2M.
-
Who are HemaCore’s investors?
Skolkovo Foundation has invested in HemaCore.
-
Who are HemaCore’s competitors?
Oscor, Kardium, Q-linea, Modality Dx, and Grifols Diagnostic Solutions are some of the 36 competitors of HemaCore.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process